Skip to main content

Table 2 Procedural characteristics

From: Minimising radiation exposure in catheter ablation of ventricular arrhythmias

 

Group 1

(n = 31)

Group 2

(n = 29)

Septal substrate related VT [number (%)]

8 (25.8)

Epicardial substrate related VT [number (%)]

6 (19.4)

Outflow tract ectopy/VT [number (%)]

18 (62.1)

Fascicular VT [number (%)]

2 (6.9)

Moderator band ectopy/VT [number (%)]

2 (6.9)

Postero-septal process ectopy/VT [number (%)]

4 (13.8)

Papillary muscle ectopy/VT [number (%)]

1 (3.4)

Other substrate/origin locations [number (%)]

28 (90.3)

4 (13.8)

Total procedural time (min)

256.9 ± 71.7

123.6 ± 42.2*

Number of ablations (number)

80.9 ± 40.5

15.4 ± 8.6*

Total ablation time (seconds)

3240 ± 1690

537 ± 357 *

Trans-septal punctures [number (%)]

28 (90.3)

8 (27.6) *

Epicardial mapping and ablation [number (%)]

3 (9.7)

4 (13.8)

Procedures with high density mapping [number (%)]

25 (80.6)

4 (13.8) *

Procedures with general anaesthesia [number (%)]

6 (19.4)

4 (13.8)

Overall Procedural Success Rate [number (%)]

24 (77.4)

26 (89.7)

Repeat procedures [number (%)]

6 (19.4)

2 (6.9)

Procedures with fluoroscopy [number (%)]

3 (9.7)

4 (13.8)

Fluoroscopy time (min)

21.2 ± 5

8.3 ± 4

DAP per procedure [Gycm2 (SD)], if fluoroscopy used

48.6 ± 23 (3 procedures)

25.4 ± 14 (4 procedures)

  1. VT ventricular tachycardia, DAP dose area product, SD standard deviation
  2. *p < 0.001; group I versus Group II